R. Rigo

Contribution of Population Pharmacokinetics to Dose Optimization of Ganciclovir-Valganciclovir in Solid-Organ Transplant Patients

H. Colom, N. Lloberas, J. Torras, 2016, Antimicrobial Agents and Chemotherapy.

Postresection parathyroid hormone and parathyroid hormone decline accurately predict hypocalcemia after thyroidectomy.

M. Navarro, P. Moreno, J. Francos, 2007, American journal of clinical pathology.

Phase I study and preclinical efficacy evaluation of the mTOR inhibitor sirolimus plus gemcitabine in patients with advanced solid tumours

H. Colom, M. Gil-Martin, X. García del Muro, 2014, British Journal of Cancer.

A multicenter, open-label, randomized, proof-of-concept phase II clinical trial to assess the efficacy and safety of icatibant in patients infected with SARS-CoV-2 (COVID-19) and admitted to hospital units without invasive mechanical ventilation: study protocol (ICAT-COVID)

C. Tebé, M. Gasa, S. Videla, 2022, Trials.

Comparison of Three Renal Function Formulas for Ganciclovir/Valganciclovir Dose Individualization in CMV-Infected Solid Organ Transplantation Patients Using a Population Approach

H. Colom, N. Lloberas, J. Torras, 2023, Clinical Pharmacokinetics.

A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction.

H. Colom, N. Lloberas, J. Torras, 2023, Kidney international.